UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in ACM Research, Inc. (NASDAQ:ACMR – Free Report) by 11.9% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 77,362 shares of the specialty retailer’s stock after selling 10,491 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in ACM Research were worth $1,570,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently bought and sold shares of the business. Millennium Management LLC raised its holdings in shares of ACM Research by 283.9% during the second quarter. Millennium Management LLC now owns 924,104 shares of the specialty retailer’s stock worth $21,310,000 after purchasing an additional 683,361 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its stake in shares of ACM Research by 9.1% in the second quarter. Allspring Global Investments Holdings LLC now owns 408,135 shares of the specialty retailer’s stock worth $9,412,000 after buying an additional 34,066 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in ACM Research by 3.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 405,858 shares of the specialty retailer’s stock worth $8,239,000 after acquiring an additional 13,879 shares during the period. Citigroup Inc. raised its position in ACM Research by 8.7% during the third quarter. Citigroup Inc. now owns 340,207 shares of the specialty retailer’s stock valued at $6,906,000 after acquiring an additional 27,178 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its position in ACM Research by 8.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 235,860 shares of the specialty retailer’s stock worth $5,439,000 after purchasing an additional 18,830 shares in the last quarter. 66.75% of the stock is owned by hedge funds and other institutional investors.
ACM Research Price Performance
ACM Research stock opened at $15.24 on Tuesday. The company has a fifty day simple moving average of $18.54 and a 200-day simple moving average of $19.56. The company has a quick ratio of 1.34, a current ratio of 2.37 and a debt-to-equity ratio of 0.10. The firm has a market capitalization of $877.92 million, a price-to-earnings ratio of 11.55 and a beta of 1.48. ACM Research, Inc. has a 52-week low of $13.87 and a 52-week high of $34.40.
Analyst Ratings Changes
A number of analysts recently issued reports on ACMR shares. Craig Hallum downgraded shares of ACM Research from a “buy” rating to a “hold” rating and lowered their price target for the stock from $30.00 to $18.00 in a report on Thursday, December 5th. Needham & Company LLC cut ACM Research from a “buy” rating to a “hold” rating and set a $25.00 target price on the stock. in a research report on Wednesday, December 4th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $30.00.
View Our Latest Analysis on ACMR
Insider Buying and Selling
In other news, Director Haiping Dun sold 15,000 shares of the company’s stock in a transaction on Friday, November 22nd. The stock was sold at an average price of $19.12, for a total transaction of $286,800.00. Following the sale, the director now owns 774,148 shares of the company’s stock, valued at approximately $14,801,709.76. This represents a 1.90 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Xiao Xing sold 8,304 shares of the company’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $20.19, for a total value of $167,657.76. Following the sale, the director now owns 3,430,206 shares in the company, valued at approximately $69,255,859.14. This trade represents a 0.24 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,244,016 shares of company stock worth $26,939,953. Company insiders own 31.24% of the company’s stock.
ACM Research Company Profile
ACM Research, Inc, together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase shift technology for flat and patterned wafer surfaces, which employs alternating phases of megasonic waves to deliver megasonic energy in a uniform manner on a microscopic level; timely energized bubble oscillation technology for patterned wafer surfaces at advanced process nodes, which provides cleaning for 2D and 3D patterned wafers; Tahoe technology for delivering cleaning performance using less sulfuric acid and hydrogen peroxide; and electro-chemical plating technology for advanced metal plating.
Further Reading
- Five stocks we like better than ACM Research
- What Are the FAANG Stocks and Are They Good Investments?
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- Trading Stocks: RSI and Why it’s Useful
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Want to see what other hedge funds are holding ACMR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ACM Research, Inc. (NASDAQ:ACMR – Free Report).
Receive News & Ratings for ACM Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ACM Research and related companies with MarketBeat.com's FREE daily email newsletter.